Transbiomed
Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$5—8m (Dealroom.co estimates Feb 2011.)
Company register number B64742901
Barcelona Catalonia (HQ & founding location)